Related Experiment Videos
Using mice to decipher the molecular genetics of brain tumors
Göran Hesselager1, Eric C Holland
1Departments of Neurosciences (Division of Neurosurgery) and Genetics and Pathology, University Hospital, Uppsala, Sweden.
Abstract:
The past decade has dramatically increased our knowledge of genetic and molecular alterations in human central nervous system tumors. Important as these alterations are for the molecular classification of tumors, their actual roles in tumorigenesis and tumor progression have long remained obscure. Lately, several mouse brain tumor models have been developed that use different gene modification strategies to replicate mutations seen in the human counterpart. These genetic models will allow discrimination between mutations that are causally related to tumor formation and mutations that are a result of tumor progression. These models also provide histologically and genetically accurate models for preclinical testing and will perhaps help us identify novel targets for therapies aimed at the mechanistic cause of the disease. We present here a review of current models, with a focus on gliomas and medulloblastomas.
Insights
Recent advances in mouse brain tumor models illuminate genetic alterations in human central nervous system tumors. These models aid in understanding tumorigenesis and developing targeted therapies for brain cancers.
Area of Science:
- Neuro-oncology
- Genetics
- Molecular Biology
Background:
- Significant progress in understanding genetic and molecular alterations in human central nervous system (CNS) tumors.
- The roles of these alterations in tumorigenesis and tumor progression remain largely unclear.
- Development of genetically engineered mouse models (GEMMs) to mimic human brain tumors.
Purpose of the Study:
- To review current mouse models for CNS tumors.
- To focus on models relevant to gliomas and medulloblastomas.
- To highlight the utility of these models in dissecting the roles of genetic mutations in tumor development and progression.
Main Methods:
- Review of existing literature on mouse brain tumor models.
- Focus on models utilizing gene modification strategies to replicate human mutations.
- Analysis of models for their histological and genetic accuracy.
Main Results:
- GEMMs enable differentiation between mutations causing tumor formation and those occurring during progression.
- These models offer accurate platforms for preclinical testing.
- Potential for identifying novel therapeutic targets based on mechanistic understanding.
Conclusions:
- Mouse brain tumor models are crucial for advancing our understanding of CNS tumor biology.
- These models facilitate the study of genetic alterations in tumorigenesis and progression.
- They hold promise for the development of targeted therapies for brain cancers.